• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足细胞功能障碍的尿标志物:足细胞蛋白和肾小囊蛋白在部分肾小球疾病中的研究进展。

Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.

机构信息

Department of Laboratory Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District Shenyang, Liaoning 110004, PR China.

出版信息

Biomark Med. 2018 Aug;12(8):927-935. doi: 10.2217/bmm-2018-0152. Epub 2018 Jul 6.

DOI:10.2217/bmm-2018-0152
PMID:29976076
Abstract

Urinary podocalyxin and nephrin are urine markers of podocyte dysfunction that may reflect the integrity of kidney's filtration barrier. Studies on their respective roles in glomerular diseases are still underway. However, the isolated and unsystematic manner in which they are being studied does not permit proper identification of their roles in each glomerular disease. As such, there is little or no appreciation of what research has already achieved and what remains to be achieved as the research direction is not clearly defined. We explored the recent studies and outlined the major findings regarding the value of both biomarkers in each of the three glomerular disease entities. Our review covered diabetic nephropathy, membranous nephropathy and IgA nephropathy.

摘要

尿足细胞蛋白和肾小球裂孔膜蛋白是反映肾小球滤过屏障完整性的足细胞功能障碍的尿标志物。关于它们在肾小球疾病中的各自作用的研究仍在进行中。然而,由于对它们的研究方式是孤立和不系统的,因此无法正确确定它们在每种肾小球疾病中的作用。因此,由于研究方向不明确,对于已经取得的成果和尚未取得的成果,人们的认识很少或没有。我们探讨了最近的研究,并概述了这两种生物标志物在三种肾小球疾病实体中的每一种中的主要发现价值。我们的综述涵盖了糖尿病肾病、膜性肾病和 IgA 肾病。

相似文献

1
Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.足细胞功能障碍的尿标志物:足细胞蛋白和肾小囊蛋白在部分肾小球疾病中的研究进展。
Biomark Med. 2018 Aug;12(8):927-935. doi: 10.2217/bmm-2018-0152. Epub 2018 Jul 6.
2
[Research on the Combined Detection of Urine UmAlb and Urinary Nephrin, Podocalyxin in Podocyte of MKR Mice with Diabetic Nephropathy].[糖尿病肾病MKR小鼠足细胞中尿微量白蛋白与尿nephrin、足突蛋白联合检测的研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Sep;46(5):722-5.
3
Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.尿足细胞蛋白聚糖是糖尿病患者足细胞损伤的早期标志物:建立一种高灵敏度 ELISA 检测尿足细胞蛋白聚糖。
Diabetologia. 2012 Nov;55(11):2913-9. doi: 10.1007/s00125-012-2661-7. Epub 2012 Aug 2.
4
Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.成年 IgA 肾病患者尿足细胞 podocalyxin 水平、尿足细胞数与组织学损伤的关系。
Clin J Am Soc Nephrol. 2012 Sep;7(9):1385-93. doi: 10.2215/CJN.08110811. Epub 2012 Jun 14.
5
Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy.尿足细胞可作为IgA肾病患者发病情况的一个指标。
Clin Lab. 2014;60(10):1709-15. doi: 10.7754/clin.lab.2014.131225.
6
Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.糖尿病正常白蛋白尿患者足细胞标志物尿排泄增加。
Nephron. 2015;131(1):34-42. doi: 10.1159/000438493. Epub 2015 Sep 5.
7
Urine podocyte mRNAs mark disease activity in IgA nephropathy.尿足细胞mRNA可标记IgA肾病的疾病活动情况。
Nephrol Dial Transplant. 2015 Jul;30(7):1140-50. doi: 10.1093/ndt/gfv104. Epub 2015 May 8.
8
[Urinary podocyte and urinary podocalyxin; markers for diabetic nephropathy].[尿足细胞与尿足突蛋白聚糖;糖尿病肾病的标志物]
Nihon Rinsho. 2016 Apr;74 Suppl 2:181-5.
9
Biomarkers of glomerular dysfunction in pre-eclampsia - A systematic review.子痫前期肾小球功能障碍的生物标志物——一项系统评价
Pregnancy Hypertens. 2018 Oct;14:265-272. doi: 10.1016/j.preghy.2018.03.002. Epub 2018 Mar 10.
10
Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.原创研究:尿nephrin作为反映各种肾脏疾病模型中足细胞功能障碍生物标志物的潜力。
Exp Biol Med (Maywood). 2016 Oct;241(16):1865-76. doi: 10.1177/1535370216651937. Epub 2016 May 22.

引用本文的文献

1
Urinary and serum biomarkers of renal injury in coronary artery bypass grafting: a prospective evaluation with new biomarkers'.冠状动脉搭桥手术中肾损伤的尿液和血清生物标志物:新生物标志物的前瞻性评估
J Bras Nefrol. 2025 Jul-Sep;47(3):e20240173. doi: 10.1590/2175-8239-JBN-2024-0173en.
2
The Spectrum of Minimal Change Disease/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research.微小病变病/局灶节段性肾小球硬化症的谱系:从发病机制到蛋白质组学生物标志物研究
Int J Mol Sci. 2025 Mar 9;26(6):2450. doi: 10.3390/ijms26062450.
3
Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases-A Cross-Sectional Study.
尿 Nephrin 和 Podocalyxin 反映各种肾小球疾病中足细胞损伤及肾脏疾病严重程度——一项横断面研究
J Clin Med. 2024 Jun 12;13(12):3432. doi: 10.3390/jcm13123432.
4
Podocalyxin in the onset of nephropathy among Indian type 2 diabetes mellitus patients.足细胞外蛋白在印度2型糖尿病患者肾病发病中的作用
Bioinformation. 2023 Dec 31;19(12):1124-1128. doi: 10.6026/973206300191124. eCollection 2023.
5
Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study.糖尿病肾病中尿及肾脏足突细胞表面蛋白和足蛋白水平:一项肾脏活检研究
Kidney Med. 2022 Nov 14;5(1):100569. doi: 10.1016/j.xkme.2022.100569. eCollection 2023 Jan.
6
Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review.新型生物标志物助力急性肾损伤早期检测:综述
Diseases. 2022 Dec 30;11(1):8. doi: 10.3390/diseases11010008.
7
An Unusual Progression of Membranous Nephropathy.膜性肾病的一种不寻常进展。
Cureus. 2022 Oct 25;14(10):e30651. doi: 10.7759/cureus.30651. eCollection 2022 Oct.
8
Early renal structural changes and potential biomarkers in diabetic nephropathy.糖尿病肾病的早期肾脏结构变化及潜在生物标志物
Front Physiol. 2022 Nov 8;13:1020443. doi: 10.3389/fphys.2022.1020443. eCollection 2022.
9
Emerging Biomarkers for Early Detection of Chronic Kidney Disease.用于慢性肾脏病早期检测的新兴生物标志物
J Pers Med. 2022 Mar 31;12(4):548. doi: 10.3390/jpm12040548.
10
PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway.蛋白磷酸酶2A通过抑制JIP4/p38丝裂原活化蛋白激酶信号通路保护足细胞免受阿霉素诱导的损伤和上皮-间充质转化。
Cytotechnology. 2021 Oct;73(5):697-713. doi: 10.1007/s10616-021-00484-1. Epub 2021 Aug 13.